Dystrophic Epidermolysis Bullosa Market Analysis and Forecast, 2025-2035: Topical Therapies Dominate DEB Market as Vyjuvek Secures Leading Position
Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Dystrophic Epidermolysis Bullosa Market - A Global and Regional Analysis: Focus on Therapy Type and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The global dystrophic epidermolysis bullosa market is driven by rising awareness, advances in early diagnosis, and improved treatment options. DEB, a rare genetic disorder characterized by fragile skin that blisters easily, significantly impairs quality of life and can lead to severe complications such as chronic wounds, scarring, and increased risk of infections.
Advances in genetic screening, biomarkers, and non-invasive imaging techniques are enabling earlier and more accurate diagnoses, which is driving the demand for more targeted therapeutic interventions. Additionally, innovations in gene therapy, such as Vyjuvek, and cell-based treatments are offering new hope for patients, improving skin healing and reducing the burden of the disease.However, challenges including the high costs of novel therapies, limited treatment options for advanced stages of the disease, and variability in patient responses complicate treatment regimens for dystrophic epidermolysis bullosa. Additionally, the rarity of the condition and disparities in healthcare infrastructure limit access to timely and standardized care, especially in low- and middle-income countries. Despite these obstacles, increasing government and private sector investments in rare disease research, along with rising awareness campaigns, are driving market growth by improving early diagnosis, enhancing patient access to care.Innovative treatments for Dystrophic Epidermolysis Bullosa (DEB), such as gene therapies such as Vyjuvek, significantly improve skin healing and reduce blistering, enhancing patients' quality of life. Early diagnosis through advanced genetic screening and non-invasive imaging enables personalized care, while digital health tools and telemedicine improve monitoring and treatment adherence. These advancements are transforming DEB into a more manageable condition, improving patient outcomes and reducing healthcare burdens.Currently, topical therapies hold the highest market share. This can be attributed to the approval and adoption of Vyjuvek (eremagene geperpavec), a topical gene therapy developed by Krystal Biotech. This approval has positioned Vyjuvek as a leading treatment option, contributing to the dominance of topical therapies in the DEB market.North America holds the highest market share in the dystrophic epidermolysis bullosa market, driven by the region's advanced healthcare infrastructure, robust reimbursement policies, and the presence of leading pharmaceutical companies actively developing and commercializing DEB therapies. Additionally, North America benefits from a high prevalence of DEB, extensive clinical research activities, and a well-established patient support network, all contributing to its leading position in the market.Demand Drivers for the Global Dystrophic Epidermolysis Bullosa Market:
Growing awareness is leading to earlier diagnosis and more identified cases of DEB.
Gene therapies and cell-based treatments such as Vyjuvek are addressing DEB's genetic roots, creating demand for innovative solutions.
Enhanced diagnostic tools enable quicker and more accurate identification of DEB. Early detection facilitates timely intervention, driving treatment demand.
Global initiatives supporting rare diseases, including DEB, are increasing treatment access.
Limitations for the Global Dystrophic Epidermolysis Bullosa Market:
Advanced therapies, such as gene and cell-based treatments, come with high price tags, limiting their accessibility.
Despite progress, gene and cell-based therapies for DEB are still in the early stages of development and are not widely available.
The approval process for novel therapies in DEB can be slow and complex, hindering the timely availability of new treatments.
Key Market Players and Competition SynopsisA detailed competitive landscape analysis helps organizations benchmark their market standing against key players. By understanding the strengths and weaknesses of competitors, companies can position themselves more effectively in the global dystrophic epidermolysis bullosa market.
Leading players in the global dystrophic epidermolysis bullosa market include:
Krystal Biotech
Castle Creek Biosciences
Abeona Therapeutics
Amryt Pharma
Phoenix Tissue Repair
InMed Pharmaceuticals
Eloxx Pharmaceuticals
RegeneRx Biopharmaceuticals
Phoenicis Therapeutics
BPGbio
Key Topics Covered:1. Global Dystrophic Epidermolysis Bullosa Market: Industry Analysis1.1 Market Overview and Ecosystem1.2 Epidemiological Analysis1.3 Key Market Trends1.4 Regulatory Landscape1.5 Pipeline Analysis1.6 Market Dynamics2. Global Dystrophic Epidermolysis Bullosa Market (by Therapy Type), Value ($million), 2023-20352.1 Gene Therapy2.2 Cell-Based Therapy2.3 Topical Therapies2.4 Small Molecule Therapy2.5 Others3. Global Dystrophic Epidermolysis Bullosa Market (by Region), Value ($Million), 2023-20353.1 North America3.2 Europe3.3 Asia-Pacific3.4 Rest-of-the-World4. Competitive Landscape and Company Profiles4.1 Competitive Landscape4.1.1 Mergers and Acquisitions4.1.2 Partnership, Alliances and Business Expansion4.1.3 New Offerings4.1.4 Regulatory Activities4.1.5 Funding Activities4.2 Company Profiles
Krystal Biotech
Castle Creek Biosciences
Abeona Therapeutics
Amryt Pharma
Phoenix Tissue Repair
InMed Pharmaceuticals
Eloxx Pharmaceuticals
RegeneRx Biopharmaceuticals
Phoenicis Therapeutics
BPGbio
For more information about this report visit https://www.researchandmarkets.com/r/h0s2ht
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Dentist Shares 1 Simple Breathing Exercise to Stop Clenching Your Jaw
Clenching your jaw and grinding your teeth can do a serious number on your teeth and jaw muscles. If you're a regular jaw-clencher, you're familiar with the soreness, tooth pain and maybe even headaches that this unconscious habit can cause. And, it might feel like there's not much you can do about clenching your teeth during the day. But a quick, expert-approved breathing exercise can help calm your body and mind in the moment, helping you de-stress and unclench in less than a minute. Expert Tip of the Day: Simple Breathing Exercise to Stop Clenching Your Jaw If you're someone who clenches your teeth or jaw during the day, "the first step is to realize that you are clenching,' Dr. Matthew Messina, a consumer advisor spokesperson for the American Dental Association and associate professor at the Ohio State University College of Dentistry, told previously. Once you catch yourself, taking a moment to perform a simple breathing exercise can help you calm down and release the tension. Why It Matters The technical term for grinding your teeth or clenching your jaw is bruxism, and this behavior can happen at night or during the day. While the specific cause of bruxism at night is still a bit of a scientific mystery, daytime clenching "is more significantly associated with stressful events than sleep-related bruxism," Dr. Elizabeth Rae Hatfield, clinical assistant professor specializing in orofacial pain at the University of Michigan School of Dentistry, tells 'If we're stressed out, one of the ways the body burns off that extra energy is by clenching and grinding the teeth,' Messina said. 'It's the body's natural defense mechanism kind of gone off the rails.' If your bruxism is left untreated, you may develop some painful and potentially serious symptoms. In particular, your teeth might show excess wear and become sensitive. You can also develop morning headaches and jaw soreness. Down the line, bruxism can put you at a greater risk for oral health problems, like gum recession and cracked or loose teeth. While you can protect your teeth from some consequences of nighttime bruxism through the use of a night guard, you can't necessarily get away with wearing your device during the day. And, if you're getting stressed while working at your desk or driving, it can be challenging to take a step back and realize what you're doing. That means catching yourself clenching — and taking the time to perform this stress-relieving biofeedback exercise — is one of the only ways to stop daytime bruxism. How to Get Started Messina shared this quick exercise he gives patients to stop clenching their jaw during the day: Start by taking a deep breath in through your nose, and hold it in while you count to four. Slowly exhale through your mouth while counting to four. Then place the palms of your hands on the sides of your face with your fingers spread out. Draw your fingers slow down the sides of your face and into your neck. Finish by taking another deep breath. An exercise like this may feel and sound a little" goofy," Messina said, "but that relaxes the jaw muscles as part of a biofeedback loop." Once you're done and feeling a little more relaxed, "you can go back on with with life from there," Messina said. TODAY's Expert Tip of the Day series is all about simple strategies to make life a little easier. Every Monday through Friday, different qualified experts share their best advice on diet, fitness, heart health, mental wellness and more. This article was originally published on
Yahoo
43 minutes ago
- Yahoo
The spice linked to lower blood sugar - and it's probably already in your kitchen
Cloves can do much more than just sweeten your baked goods. Used for thousands of years in traditional medicine, the warm spice commonly used in pumpkin pie and mulled wine may also benefit your gum health and lower your blood pressure, according to years of research. 'The antibacterial properties of cloves help kill harmful bacteria inside your mouth,' Idaho's Summit Dental Group explains. 'This makes cloves highly effective in controlling plaque and reducing the risk of gum disease.' Clove oil serves as a natural antimicrobial substance, stopping the growth of bacteria and fungi, according to studies. Just a few drops are enough. People shouldn't add more than 10 to 15 drops in an ounce of water, according to the National Association for Holistic Aromatherapy. Clove oil can be an irritant for some people, particularly on the skin. This is because cloves contain eugenol, a yellow-colored compound commonly found in cinnamon and bay leaves. Eugenol affects the our ability to stop bleeding, according to the Cleveland Clinic. It can be harmful when adults take as little as 10 milliliters of eugenol, according to Mount Sinai. Children should not consume it. Still, eugenol is generally safe in the quantities found in food products made with ground cloves. Most pumpkin pie recipes don't call for more than a teaspoon of the spice. Eugenol has the ability to kill yeast, which can be the result of an overgrowth of fungus in the mouth. The compound is also what researchers say can lower your blood sugar levels. After taking 250 milligrams of clove extract daily for 30 days, researchers said participants in a 2019 study had significantly lower blood sugar after meals. Cloves are also packed with essential minerals. The spice has calcium to maintain strong bones, magnesium that can regulate blood sugar and calcium levels, potassium that helps the nerves and supports heart health, and vitamin K, which helps keep arteries healthy. Eugenol may help improve bone mass as well, according to research on animals. Lastly, cloves are a natural antioxidant, the substances found in foods that can prevent damage to cells and DNA. Experts say people need a variety of antioxidant-rich foods each day, such as berries and nuts. 'Antioxidants are almost like a shield around your cells, like a blanket around them to protect them from oxidative damage,' registered dietitian Julia Zumpano explained to the Cleveland Clinic.
Yahoo
an hour ago
- Yahoo
Union representing 22,000 Alberta health professionals reaches tentative agreement
The president of the Health Sciences Association of Alberta says he is reluctantly recommending union members ratify a tentative deal that will grant workers at least a 12 per cent wage increase in four years. "Did we get everything we were looking for? No," said HSAA president Mike Parker in an interview on Friday. "The people who need to make that decision on next steps are the members of HSAA who have to work under this agreement." Parker says the proposal is the best deal union leaders think members can get out of the employers. Representatives from the union and provincial health employers, represented by Alberta Health Services, struck a compromise on Thursday. An HSAA news release says it would give 22,000 members in 160 professions three per cent wage increases each year for four years, from April 1, 2024 to March 31, 2028. HSAA has another 8,000 members who are not included in the deal. About a fifth of 22,000 HSAA workers, who are among the lowest paid in the union, would also get a boost to bring their salaries closer to those of colleagues in other provinces, Parker said. Specific professionals, including primary care paramedics, emergency communication officers, advanced care paramedics, psychologists and perfusionists would also receive extra wage boosts. The news release said the arrangement would include better health benefits for workers, job-protected leave for education upgrades, and better on-call and preceptor pay, among other perks. Other affected workers include physiotherapists, pharmacists, respiratory therapists, medical imaging technologists, and many others employed by AHS, four other new provincial health agencies, Lamont health care centre and Camrose's Bethany Nursing Home. Alberta Finance Minister Nate Horner said in a statement Thursday he was pleased the parties had reached a tentative pact after 16 months with no contract. "The partnership between the two parties is a testament to the importance of these health-care professionals and the services they provide to Albertans, and our health system," Horner said. His press secretary was not able to provide the potential cost to the treasury, should workers vote to accept the deal. Professor: agreement could set tone for other unions Parker said by last weekend, negotiations had hit an impasse. "We contacted the highest levels of government and said, 'Look it. This is not good enough,' " he said. Parker said they came away with a letter of understanding that committed the parties to doing a detailed analysis of wages for different professionals across western Canada and Ontario. He said this leaves the door open to potential wage increases for some workers before the tentative agreement expires. Workers will have two weeks to vote on the agreement online, beginning on Aug. 28. Athabasca University human resources and labour relations Prof. Jason Foster said the pact could be a tough sell to some of the union members who wouldn't benefit from extra wage boosts. "They probably have a sense that their members aren't going to be particularly thrilled with it," Foster said of HSAA leaders. Member expectations were high, said Foster, after the United Nurses of Alberta inked a spring deal that gives members about a 20 per cent wage hike over four years. The nurses' agreement came after they rejected an earlier recommendation from a mediator in October 2024. Unionized Alberta teachers also rejected a mediator's settlement proposal in May. "I don't think this is over yet," Foster said of HSAA's tentative agreement. If HSAA members vote to accept the offer, the agreement could set a precedent for other provincial public-sector unions also trying to negotiate new contracts. Some post-secondary employees have also settled for 12 per cent raises over four years, he said. The Alberta Teachers' Association's 51,000 members are in a position to strike with 72 hours notice. Unionized Alberta government workers are in mediation. An Aug. 8 update on the Alberta Union of Provincial Employees (AUPE) website says if this round of negotiations is unsuccessful, they will serve strike notice on or before Sept. 6 and walk off the job 72 hours later. "They have been the most willing and most vocal about their willingness to go on strike," said Foster, who added that the union has spent the summer preparing members for a possible strike. AUPE health-care workers have also been without a contract since April 2024 and have asked for the appointment of a mediator.
